Sodium–glucose cotransporter 2 inhibitors and risk of nephrolithiasis

被引：0
|
作者：
Kasper B. Kristensen
Daniel P. Henriksen
Jesper Hallas
Anton Pottegård
Lars C. Lund
机构：
[1] University of Southern Denmark,Clinical Pharmacology and Pharmacy, Department of Public Health
[2] Odense University Hospital,Department of Clinical Biochemistry and Pharmacology
来源：
Diabetologia | 2021年 / 64卷
关键词：
Cohort studies; Databases; Dipeptidyl peptidase 4 inhibitors; Glucagon–like peptide 1 receptor agonists; Nephrolithiasis; Observational studies; Sodium–glucose cotransporter 2 inhibitors; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1563 / 1571
页数：8
相关论文
共 50 条
  • [1] Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis
    Kristensen, Kasper B.
    Henriksen, Daniel P.
    Hallas, Jesper
    Pottegard, Anton
    Lund, Lars C.
    DIABETOLOGIA, 2021, 64 (07) : 1563 - 1571
  • [2] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice
    Hsiao, Po-Ren
    Wei, James Cheng-Chung
    JAMA INTERNAL MEDICINE, 2024, 184 (07)
  • [3] Sodium-glucose cotransporter-2 inhibitors reduce risk of nephrolithiasis
    Di Lellis, Maddalena Angela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (12) : 674 - 675
  • [4] Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary C.
    Zakoul, Heidi
    Wexler, Deborah J.
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2024, 184 (03) : 265 - 274
  • [5] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice-Reply
    Paik, Julie M.
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2024, 184 (07)
  • [6] Sodium glucose cotransporter 2 inhibitors and gout risk
    Lai, Shih-Wei
    Hwang, Bing-Fang
    Liu, Chiu-Shong
    Liao, Kuan-Fu
    CLINICAL RHEUMATOLOGY, 2024, 43 (02) : 835 - 836
  • [7] Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk
    Arnott, Clare
    Fletcher, Robert A.
    Neal, Bruce
    HEART FAILURE CLINICS, 2022, 18 (04) : 645 - 654
  • [8] Comment on “Sodium glucose cotransporter 2 inhibitors and gout risk”
    Shih-Wei Lai
    Bing-Fang Hwang
    Chiu‑Shong Liu
    Kuan-Fu Liao
    Clinical Rheumatology, 2024, 43 : 835 - 836
  • [9] Sodium Glucose Cotransporter 2 Inhibitors
    White, John R., Jr.
    MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (01) : 131 - +
  • [10] SODIUM GLUCOSE COTRANSPORTER 2 INHIBITORS Hydration must be maintained in patients taking sodium glucose cotransporter 2 inhibitors
    Auersperg, Edward V.
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
12345